2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Rush Enterprises' Canadian subsidiary, RTC-Canada, and the company as guarantor amended two credit agreements with Bank of Montreal, both effective August 4, 2026. The amendments extend the expiration dates to December 31, 2029, and one amendment removes a $20.0 million CAD accordion feature that RTC-Canada said it does not need.
Second amendment to the BMO Revolving Lease and Rental Credit Agreement extends expiration to December 31, 2029
The $20.0 million CAD accordion feature is removed because RTC-Canada determined it does not need it
Fifth amendment to the Amended and Restated BMO Wholesale Financing and Security Agreement (floor plan credit) extends expiration to December 31, 2029
Both amendments were effective August 4, 2026; the filing was dated August 5, 2026
Twist Bioscience priced an upsized public offering of 3,125,000 common shares at $96.00 per share on August 4, 2026, for expected gross proceeds of $300.0 million. On August 5, 2026, the underwriters exercised in full their option to buy 468,750 additional shares, and the company expects net proceeds of about $327.1 million, with closing expected on or about August 6, 2026. The company says it will use the proceeds, together with existing cash, for research and development, manufacturing capacity expansion, product offerings, and working capital.
Priced 3,125,000 shares at $96.00 per share, with expected gross proceeds of $300.0 million (August 4, 2026)
Underwriters exercised in full their option to purchase 468,750 additional shares at $96.00 per share (August 5, 2026)
Expected net proceeds of about $327.1 million, including the option shares; closing expected on or about August 6, 2026
Offering made under a Form S-3 automatic shelf registration filed June 18, 2026; Goldman Sachs, William Blair, Leerink Partners and Guggenheim are the underwriters
AbbVie agreed on August 4, 2026 to sell $9.93 billion in net proceeds of senior notes across eight series maturing from 2028 to 2066. The company says it will use the proceeds to fund part of the cash payments for its acquisition of Apogee Therapeutics and for general corporate purposes, including debt repayment or repurchase. The offering adds debt to the balance sheet, but it also reduces commitments under a $10.0 billion term loan facility that was arranged for the Apogee deal.
Eight series of notes totaling $9.93 billion in estimated net proceeds, including $1.5 billion of 4.875% notes due 2031 and $1.5 billion of 5.300% notes due 2036
Proceeds are expected to fund part of the cash payments for the Apogee Therapeutics acquisition
Closing is expected on August 18, 2026, subject to customary closing conditions
Net proceeds will reduce commitments under the $10.0 billion 364-Day delayed draw term loan facility
Alto Ingredients reported second quarter 2026 net income attributable to common stockholders of $11.4 million, or $0.15 per diluted share, compared with a net loss of $11.3 million in the prior-year quarter. The company also established a $50 million at-the-market equity program, which gives it a way to sell new shares to fund future projects if it chooses.
Q2 2026 net sales were $245.7 million, up from $218.4 million; gross profit was $16.6 million versus a gross loss of $1.9 million
Q2 2026 adjusted EBITDA was $23.7 million, compared with negative $0.2 million a year earlier
Company established a $50 million at-the-market equity program; June 30, 2026 borrowing availability was $106 million
Net income for Q2 2026 included $5.1 million in transferable tax credits, net
BOA Acquisition Corp. II, a special purpose acquisition company, closed its initial public offering on August 5, 2026, selling 14,375,000 units at $10.00 each, including 1,875,000 units from the full exercise of the underwriters' over-allotment option. The $143.75 million in IPO proceeds was placed in a trust account, and the filing says those funds will not be released until a business combination is completed, shareholders redeem public shares in specified circumstances, or the company liquidates if no business combination is completed within 12 months.
IPO closed August 5, 2026: 14,375,000 units at $10.00 per unit, gross proceeds of $143,750,000 before underwriting discounts and offering expenses
$143,750,000 placed in a trust account with Odyssey Transfer and Trust Company, as trustee
Private placement of 221,500 units at $10.00 for $2,215,000; sponsor pays $13,333 per month for administrative services
Five new directors appointed August 3, 2026; units began trading on Nasdaq as THEOU on August 4, 2026
On August 5, 2026, Magnolia's operating subsidiaries closed a $500.0 million offering of 6.625% senior notes due August 15, 2034. The proceeds, along with a July 22, 2026 Class A stock offering, revolving credit borrowings and cash on hand, are to fund the cash consideration for the pending acquisition of WildFire Intermediate Holdings, LLC. The notes add a fixed debt obligation tied to that deal, which must be redeemed if the acquisition is not completed by March 19, 2027.
$500.0 million principal at 6.625% per year, maturing August 15, 2034, with interest paid semi-annually starting February 15, 2027.
Proceeds, with July 22, 2026 stock offering proceeds, revolver borrowings and cash on hand, fund the cash payment for 100% of WildFire Intermediate Holdings, LLC from WildFire Energy I LLC.
Notes must be redeemed at issue price plus accrued interest if the acquisition is not completed by March 19, 2027, or if Magnolia Operating decides not to pursue it.
Holders may require repurchase at 101% of principal plus accrued interest upon certain changes of control.
AES amended two credit agreements on August 5, 2026, extending the termination date of the Citi revolving commitments from August 23, 2027 to August 23, 2028. The SMBC revolving commitments are set to be extended from December 6, 2026 to December 6, 2027, subject to customary closing conditions. Other terms of both credit agreements remain unchanged, and the filing does not state borrowing amounts.
Citi Credit Agreement revolver termination date extended from August 23, 2027 to August 23, 2028
SMBC Credit Agreement revolver termination date to be extended from December 6, 2026 to December 6, 2027, subject to customary closing conditions
All other terms of both credit agreements remain in effect
Amendments filed as Exhibits 10.1 (Citi) and 10.2 (SMBC)
On August 5, 2026, Millrose Properties entered into Amendment No. 1 to its Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment reduces the interest rate on the loans by 0.25% per annum, which lowers the company's borrowing cost under the facility.
Amendment No. 1 amends the Amended and Restated Credit Agreement dated March 25, 2026.
The amendment reduces the rate at which the loans bear interest by 0.25% per annum.
JPMorgan Chase Bank, N.A. serves as administrative agent; the full amendment is filed as Exhibit 10.1.
On August 5, 2026, American Express announced a proposed public offering of depositary shares, each representing a 1/1,000th interest in a new series of Fixed Rate Reset Noncumulative Preferred Shares, Series E. The company may use the proceeds for general corporate purposes, including partially or fully redeeming its 3.550% Series D preferred shares, but pricing, closing and any redemption are subject to market conditions and not assured.
Proposed offering of depositary shares, each representing a 1/1,000th interest in a Series E preferred share, announced August 5, 2026
Net proceeds intended for general corporate purposes, including possible partial or full redemption of the 3.550% Series D preferred shares
Filing states there is no assurance the offering will price or close, or that the Series D shares will be redeemed, or the amount and timing of any redemption
Details are in a preliminary prospectus supplement dated August 5, 2026; the filing is not an offer to sell or a notice of redemption
On August 5, 2026, Postal Realty Trust and its operating partnership entered into sales agreements with eight sales agents and several forward purchasers covering up to $300,000,000 of Class A common stock, replacing its prior at-the-market program. The company says net proceeds would be used for general corporate purposes, including property acquisitions, dividends, capital expenditures and debt repayment, which could dilute existing shareholders if shares are issued.
Agreements cover shares with an aggregate offering price of up to $300,000,000, sold through sales agents or forward sellers, or to agents as principal.
Commissions will not exceed 2.0% of gross sales price, except in certain stated circumstances.
The company will not initially receive proceeds from borrowed shares sold under forward sale agreements; it may receive contingency premiums instead.
Prior at-the-market offering agreements were terminated concurrently.
On July 31, 2026, Cencora and its subsidiary Innomar Strategies entered into an amended and restated credit agreement that raises the commitments on its multi-currency revolving credit facility from $5.5 billion to $7.0 billion and extends the maturity date to July 2031. The same day, the company amended its receivables securitization facility, reducing its size from $1.5 billion to $1.0 billion while increasing the accordion feature to $1.0 billion, which gives the company the option to increase commitments by that amount, subject to bank approval.
Revolving credit facility commitments increase from $5.5 billion to $7.0 billion, with maturity extended to July 2031.
Interest on revolver borrowings ranges from 69.5 to 110 basis points over Term SOFR and other benchmark rates, based on public debt ratings.
Receivables securitization facility decreases from $1.5 billion to $1.0 billion; accordion feature increases from $500 million to $1.0 billion.
Both agreements are dated July 31, 2026 and were filed as Exhibits 10.1 and 10.2.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.